Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle

BACKGROUND: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182-3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and migration5, but its role in GDM is largely unknown. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Jinghong, Chen, Youfang, Huang, Jingying, Wu, Ruoying, Dong, Zhenzhu, Gao, Yuling, Chen, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941230/
https://www.ncbi.nlm.nih.gov/pubmed/35330559
http://dx.doi.org/10.4274/balkanmedj.galenos.2021.2021-8-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941230/
https://www.ncbi.nlm.nih.gov/pubmed/35330559
http://dx.doi.org/10.4274/balkanmedj.galenos.2021.2021-8-140

Ejemplares similares